2019-03-17 14:35:00 Sun ET
technology antitrust competition bilateral trade free trade fair trade trade agreement trade surplus trade deficit multilateralism neoliberalism world trade organization regulation public utility current account compliance
U.S. trade rep Robert Lighthizer proposes America to require regular touchpoints to ensure Sino-U.S. trade deal enforcement. America has to maintain the threat of tit-for-tat tariffs on Chinese goods for years even though the Trump administration seeks to achieve a new agreement with China to end the prohibitively costly Sino-U.S. trade war. U.S. trade negotiators and lawmakers need to monitor-and-enforce Chinese compliance with the new trade rules. The Trump team aims to eradicate the $350 billion bilateral U.S. trade deficit. In response, the Chinese administration offers to buy $1.2 trillion U.S. goods and services over the next 6 years. Also, the Trump administration has to deter the Chinese government from forcing U.S. tech companies to involuntarily transfer trade secrets, tech advances, and other major intellectual properties such as patents, trademarks, and copyrights.
On balance, tariffs remain an important instrument for the Trump administration to push China to start structural trade policy changes in light of the specific perennial enforcement issue. Due to few major surprises, U.S. stock market indices such as from S&P 500 to Dow Jones and NASDAQ remain steady after the congressional testimonies by U.S. trade envoy Robert Lighthizer and Fed Chair Jerome Powell.
If any of our AYA Analytica financial health memos (FHM), blog posts, ebooks, newsletters, and notifications etc, or any other form of online content curation, involves potential copyright concerns, please feel free to contact us at service@ayafintech.network so that we can remove relevant content in response to any such request within a reasonable time frame.
2019-01-10 17:31:00 Thursday ET

The recent Bristol-Myers Squibb acquisition of American Celgene is the $90 billion biggest biotech deal in history. The resultant biopharma goliath would be
2017-02-13 09:35:00 Monday ET

JPMorgan Chase CEO Jamie Dimon says President Trump has now awaken the *animal spirits* in the U.S. stock market. The key phrase, animal spirits, is the
2020-04-24 11:33:00 Friday ET

Disruptive innovations tend to contribute to business success in new blue-ocean markets after iterative continuous improvements. Clayton Christensen and
2019-06-07 04:02:05 Friday ET

The world seeks to reduce medicine prices and other health care costs to better regulate big pharma. Nowadays the Trump administration requires pharmaceutic
2018-03-07 07:34:00 Wednesday ET

President Trump tweets his key decision to oust State Secretary Rex Tillerson after several months of intense disagreement over diplomatic affairs. Trump so
2023-03-14 16:43:00 Tuesday ET

Several feasible near-term reforms can substantially narrow the scope for global tax avoidance by closing information loopholes. Thomas Pogge and Krishen